Vincerx Pharma Inc (VINC)

FINANCE: CORPORATE FINANCE
SIC: PHARMACEUTICAL PREPARATIONS

260 SHERIDAN AVENUE PALO ALTO, CA 94306

Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerx’s current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company intends to develop multiple products through clinical proof-of-concept and potentially through Accelerated Approval in the United States.

Data as of 2021-08-02 09:13:32 -0400
Market Cap232.154 Million Shares Outstanding17.521 Million Avg 30-day Volume114.765 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.39 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low26.75 / 9.95 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from VINC instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 1 200.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 37 19 94.74% 22 (1.29%) 13 (0.75%) 69.23%
13F shares: 8.861 Million 3.804 Million 132.97% 5.617 Million 3.274 Million 71.58%
% Ownership 63.3668 27.2001 132.97% 40.1696 23.4121 71.58%
New Positions: 22 13 69.23% 10 9 11.11%
Increased Positions 7 1 600.0% 5 1 400.0%
Closed Positions 4 7 -42.86% 1 4 -75.0%
Reduced Positions 5 4 25.0% 5 3 66.67%
Total Calls 92.398 Thousand 92.398 Thousand 0.0% 92.398 Thousand 92.398 Thousand 0.0%
Total Puts
PUT/CALL Ratio 0.0 0.0 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VINC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VINC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

50.9 Thousand total shares from 9 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BUSHNELL LAURA I.

  • Director
1,800 2021-06-30 4

HWANG SOOIN CHIEF BUSINESS OFFICER

  • Officer
385,575 2021-06-30 2

MCDONALD ANDREW I

  • Director
828,471 2021-06-29 4

LOWE CHRISTOPHER P.

  • Director
10,000 2021-06-29 4

HAMDY AHMED MD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,626,029 2021-06-29 3

SEELENBERGER ALEXANDER A. CHIEF FINANCIAL OFFICER

  • Officer
7,950 2021-06-29 3

LEE JOHN H.

  • Director
799 2021-06-29 4

THOMAS TOM C SEE REMARKS

  • Officer
207,522 2021-06-29 3

DRUKER BRIAN

  • Director
20,000 2021-05-13 3

SALVA FRANCISCO D.

  • Director
20,000 2021-05-13 3

STEVENS RUTH E.

  • Director
20,000 2021-05-13 2

GARBAN HERMES DE JESUS CHIEF MEDICAL OFFICER

  • Officer
0 2021-03-01 2

MCCAMISH MARK ANTHONY

  • Director
0 2020-12-23 2

IZUMI RAQUEL E. CHIEF OPERATIONS OFFICER

  • Officer
  • Director
  • 10% Owner
0 2020-12-23 2

BYRD JOHN C.

  • 10% Owner
0 2020-12-23 2

GROSSMAN JONAS

  • Director
  • 10% Owner
1,000,000 2020-03-10 0

DOBKIN DAVID CHIEF FINANCIAL OFFICER

  • Officer
  • Director
1,570,000 2020-03-10 0

RICE MICHAEL YEHUDA CHIEF OPERATING OFFICER

  • Officer
  • Director
  • 10% Owner
1,570,000 2020-03-10 0

RICE MICHAEL CHIEF OPERATING OFFICER

  • Officer
  • Director
  • 10% Owner
1,701,000 2020-03-05 0

WALKER KARIN L

  • Director
6,000 2020-03-05 0

SCHWARTZ BRIAN

  • Director
6,000 2020-03-05 0

DENNIS BARRY

  • Director
6,000 2020-03-05 0

LIFESCI INVESTMENTS, LLC

  • 10% Owner
1,701,000 2020-03-05 0

ZIEGLER JOHN STEVEN

  • Director
6,000 2020-03-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BUSHNELL LAURA I. - Director

2021-06-30 19:02:03 -0400 2021-06-30 P 1,800 $12.94 a 1,800 direct

LOWE CHRISTOPHER P. - Director

2021-06-30 18:59:14 -0400 2021-06-30 P 3,600 $12.66 a 10,000 direct

HWANG SOOIN - Officer CHIEF BUSINESS OFFICER

2021-06-30 18:56:42 -0400 2021-06-30 P 500 $12.66 a 385,575 direct

THOMAS TOM C - Officer SEE REMARKS the thomas family revocable trust, dated 9/11/2012

2021-06-30 18:57:08 -0400 2021-06-29 P 2,000 $12.58 a 2,000 indirect

LEE JOHN H. - Director

2021-07-01 18:52:42 -0400 2021-06-29 P 799 $12.72 a 799 direct

SEELENBERGER ALEXANDER A. - Officer CHIEF FINANCIAL OFFICER

2021-06-30 18:59:34 -0400 2021-06-29 P 7,950 $12.61 a 7,950 direct

MCDONALD ANDREW I - Director

2021-07-01 06:05:26 -0400 2021-06-29 P 20,000 $12.38 a 20,000 direct

HAMDY AHMED MD - Director - Officer CHIEF EXECUTIVE OFFICER the hamdy family trust dated 10/7/2015

2021-06-30 19:02:45 -0400 2021-06-29 P 7,830 $12.77 a 7,830 indirect

LOWE CHRISTOPHER P. - Director

2021-06-30 18:59:14 -0400 2021-06-29 P 6,400 $12.59 a 6,400 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VINCERX PHARMA INC VINC 2021-08-02 22:15:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 21:45:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 21:15:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 20:45:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 20:15:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 19:45:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 19:15:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 18:45:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 18:15:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 17:45:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 17:15:03 UTC -6.1576 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 16:45:03 UTC -6.1376 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 16:15:03 UTC -6.1376 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 15:45:03 UTC -6.1376 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 15:15:03 UTC -6.1376 6.2176 80000
VINCERX PHARMA INC VINC 2021-08-02 14:45:03 UTC -6.3372 6.4172 80000
VINCERX PHARMA INC VINC 2021-08-02 14:15:03 UTC -6.3372 6.4172 80000
VINCERX PHARMA INC VINC 2021-08-02 13:45:03 UTC -6.3372 6.4172 80000
VINCERX PHARMA INC VINC 2021-08-02 13:15:04 UTC -6.3372 6.4172 80000
VINCERX PHARMA INC VINC 2021-08-02 12:45:03 UTC -6.3372 6.4172 80000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments